Industry's neglect of prescribing information for children

Peterson, Bob; Hébert, Paul C.; MacDonald, Noni; Rosenfield, Daniel; Stanbrook, Matthew B.; Flegel, Ken
June 2011
CMAJ: Canadian Medical Association Journal;6/14/2011, Vol. 183 Issue 9, p994
Academic Journal
The authors reflect on the failure of the pharmaceutical industry to submit evidence supporting safe pediatric doses and dosing intervals to Health Canada. The authors state that according to the "Compendium of Pharmaceuticals and Specialties" (CPS), there is insufficient evidence to support the use of Celebrex in juvenile idiopathic arthritis. They suggest that Canadian children can be protected by asking politicians to enact legislation similar to the U.S. Pediatric Research Equity Act.


Related Articles

  • Eye on Washington. Asch-Goodkin, Judith // Contemporary Pediatrics;Feb2007, Vol. 24 Issue 2, p16 

    The article presents health-related news briefs in the U.S. Congress voted 253 to 174 to broaden federal support for embryonic stem cell research. The Centers for Disease Control and Prevention (CDC) is warning clinicians and parents of the side effects of over-the-counter cough and cold...

  • Abbott: another promising year for Humira.  // PharmaWatch: Monthly Review;Jun2007, Vol. 6 Issue 6, p20 

    The article reports that Abbott Laboratories Inc. seeks an approval for the marketing of Humira as a treatment for juvenile rheumatoid arthritis (JRA) in the U.S. and Europe. Other than the approval of Humira as a therapy for rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis,...

  • Health Canada won't guarantee imports.  // Drug Store News;5/19/2003, Vol. 25 Issue 7, p1 

    Reports that Health Canada will not guarantee drugs exported to the United States.

  • Plain language drug labels:. Cross, Catherine // CMAJ: Canadian Medical Association Journal;9/17/2013, Vol. 185 Issue 13, pE626 

    The article reports on a 75-day stakeholder consulting period being conducted by Health Canada before implementing rules aimed at ensuring that drug labels are written in plain, understandable language and preventing confusion over drug names, as of September 2013.

  • Pan-Canadian opioid strategy to be released amid brouhaha. Miller, Adam // CMAJ: Canadian Medical Association Journal;2/5/2013, Vol. 185 Issue 2, pE89 

    The article offers information on the issues related to opioids strategy in Canada. As mentioned, Health Canada, department of the government of Canada with responsibility for national public health, has provided financial support for the development of a pan-Canadian strategy to combat...

  • Waits for Access to New Biological and Pharmaceutical Medicines: Evidence of Government Failure. Skinner, Brett J.; Rovere, Mark // Fraser Forum;Jun2007, p7 

    The article presents the evidences of the delayed approval of drugs by the federal government in Canada. According to a study, provincial officials wait longer to make such drugs eligible despite being declared safe and effective by Health Canada due to differences involving the kind of drugs...

  • Coping with juvenile arthritis.  // Current Health 1;May95, Vol. 18 Issue 9, p30 

    Offers suggestions on how to cope with juvenile arthritis (JRA). Symptoms of JRA; Treatment options for JRA; Case example.

  • Management of juvenile arthritis.  // American Family Physician;6/1/94, Vol. 49 Issue 8, p1963 

    Discusses the basic principles of management of juvenile chronic arthritis. Control of inflammatory process; Limitation of pain; Maintenance of joint position and function; Maintenance of an age-appropriate psychosocial educational environment; Maintenance of surveillance and management of...

  • Literature reviews. Lampe, John B.; Jacobs, Jerry C. // Clinical Pediatrics;May1997, Vol. 36 Issue 5, p306 

    Presents a summary of the paper `Sulfasalazine Therapy for Juvenile Rheumatoid Arthritis,' by Imundo L., Jacobs J., et al. Efficacy of sulfasalazine therapy; Comments.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics